Get started
Author

Devis Benfaremo

Observed names: BENFAREMO, DEVIS, BENFAREMO, Devis, Benfaremo D, Benfaremo, Devis, D Benfaremo, D. BENFAREMO, D. Benfaremo
Observed institutions: University of Messina, Marche Polytechnic University, Jichi Medical University, Mario Negri Institute for Pharmacological Research, Oulu University Hospital, Turku University Hospital, University Hospital Zurich, Azienda Ospedaliero-Universitaria delle Marche, University of Palermo
ORCID: 0000-0002-9867-2360
Observed ORCID: 0000-0002-9867-2360
OpenAlex ID: A5022490646
Diagnosis and management of leukocytoclastic vasculitis
2021 · Paolo Fraticelli, Devis Benfaremo, et al. · Internal and Emergency Medicine · 160
PDF
Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19
2020 · Salvatore Piano, Andrea Dalbeni, et al. · Liver International · 143
PDF
Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
2018 · Devis Benfaremo, Lucia Manfredi, et al. · Current Drug Safety · 73
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic
2018 · Michele Maria Luchetti, Devis Benfaremo, et al. · Clinical Rheumatology · 60
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis
2017 · Marco Di Carlo, Michele Maria Luchetti, et al. · Clinical Rheumatology · 48
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis
2022 · Chiara Paolini, Silvia Agarbati, et al. · International Journal of Molecular Sciences · 47
PDF
Safety of intermediate dose of low molecular weight heparin in COVID-19 patients
2020 · Massimo Mattioli, Devis Benfaremo, et al. · Journal of Thrombosis and Thrombolysis · 47
PDF
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis
2020 · Michele Maria Luchetti, Francesco Ciccia, et al. · Lara D. Veeken · 38
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
2022 · Devis Benfaremo, Silvia Svegliati, et al. · Biomedicines · 37
PDF
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis.
2018 · Fausto Salaffi, Marco Di Carlo, et al. · PubMed · 35
Biologics in Inflammatory and Immunomediated Arthritis
2017 · Michele M. Luchetti, Devis Benfaremo, et al. · Current Pharmaceutical Biotechnology · 34
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
2023 · Corrado Campochiaro, Giacomo De Luca, et al. · RMD Open · 33
PDF
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study
2022 · Giuseppe Pio Martino, Devis Benfaremo, et al. · Internal and Emergency Medicine · 30
PDF
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease
2018 · Michele Maria Luchetti, Francesco Ciccia, et al. · The Journal of Rheumatology · 30
PDF
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review
2021 · Fabio Massimo Perrotta, Silvia Scriffignano, et al. · Rheumatology and Therapy · 29
PDF
Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
2019 · Devis Benfaremo, Armando Gabrielli · Cells · 29
PDF
Certolizumab pegol for the treatment of psoriasis
2017 · A. Campanati, D. Benfaremo, et al. · Expert Opinion on Biological Therapy · 29
Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
2021 · Giuseppe Murdaca, Giovanni Noberasco, et al. · Vaccines · 28
PDF
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases
2020 · Devis Benfaremo, Michele Maria Luchetti, et al. · The Journal of Rheumatology · 28
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis
2019 · Michele Maria Luchetti, Devis Benfaremo, et al. · European Journal of Internal Medicine · 28
Enteropathic spondyloarthritis: Results from a large nationwide database analysis
2019 · Andrea Picchianti-Diamanti, Roberto Lorenzetti, et al. · Autoimmunity Reviews · 26
PDF
Biologics in Inflammatory Immune-mediated Systemic Diseases
2017 · Gianluca Moroncini, Giovanni Calogera, et al. · Current Pharmaceutical Biotechnology · 25
Putative functional pathogenic autoantibodies in systemic sclerosis
2020 · Devis Benfaremo, Silvia Svegliati Baroni, et al. · European Journal of Rheumatology · 23
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study
2017 · Michele Maria Luchetti, Devis Benfaremo, et al. · World Journal of Gastroenterology · 23
PDF
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren’s syndrome
2016 · Paolo Fraticelli, Patrizia Bagnarelli, et al. · Lara D. Veeken · 22
Works count: 127
Citation count: 1,389
H-index: 23
I10-index: 37
Year
Topic
Type